Last reviewed · How we verify

NCT07518758: PolypOxy

Acute Effect of Polyphenols Supplementation on Endothelial Function and Exercise Related Markers, in Physically Active Healthy Volunteers.

Active, enrolled NA Last updated 13 April 2026
What this trial tests

NA trial testing Oral administration in Vasodilation in 38 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
1 September 2025
Primary endpoint
20 April 2026
27 April 2026

Quick facts

Lead sponsorNexira
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingtriple
Primary purposeother
Enrollment38
Start date1 September 2025
Primary completion20 April 2026
Estimated completion27 April 2026
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Nexira

Who can join

Adults 35 to 55, any sex, with Vasodilation or Exercise. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the effect of acute polyphenols supplementation on vasodilation and related markers along with exercise related markers (notably performance, respiratory exchanges, perceived exertion), before, during and after a hypoxic moderate-intensity exercise in healthy recreative volunteers.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Oral administration

Trials testing the same drug.

Other recruiting trials for Vasodilation

Currently open trials in the same condition.

Other Nexira trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07518758.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing